Drug Resistance, NeoplasmAntineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsCell Line, TumorDoxorubicinCisplatinDrug Resistance, MultipleNeoplasmsApoptosisDrug Screening Assays, AntitumorAntibiotics, AntineoplasticPaclitaxelChemotherapy, AdjuvantEtoposideCell SurvivalGene Expression Regulation, NeoplasticRadiation, IonizingRadiation DosageDrug ResistanceP-GlycoproteinBreast NeoplasmsOvarian NeoplasmsXenograft Model Antitumor AssaysTumor Cells, CulturedRadiation InjuriesCell ProliferationTreatment OutcomeAntineoplastic Agents, PhytogenicLung NeoplasmsNeoplastic Stem CellsCombined Modality TherapyRadiation ToleranceDose-Response Relationship, RadiationX-Linked Inhibitor of Apoptosis ProteinDrug Resistance, MicrobialProto-Oncogene Proteins c-bcl-2Signal TransductionDrug Resistance, BacterialDrug Delivery SystemsNeoplasm ProteinsRadiationPrognosisTumor Suppressor Protein p53Tumor Markers, BiologicalBlotting, WesternCyclophosphamideCamptothecinApoptosis Regulatory ProteinsDrug CarriersMice, NudeDose-Response Relationship, DrugRadiation ProtectionGene Expression ProfilingRadiation MonitoringReverse Transcriptase Polymerase Chain ReactionEllipticinesAntimetabolites, AntineoplasticInhibitory Concentration 50Time FactorsDrug SynergismDNA DamageVinblastineOrganoplatinum CompoundsDaunorubicinGene ExpressionAntineoplastic Agents, AlkylatingMethotrexateMolecular StructureBleomycinDisease-Free SurvivalDrug DesignDNA Topoisomerases, Type IISurvival AnalysisDisease ResistanceMitoxantroneTaxoidsPlatinumRadiotherapyNeoadjuvant TherapyMutationDrug Administration ScheduleMitomycinCarboplatinCell CycleEnzyme InhibitorsNeoplasm StagingMicroRNAsMultidrug Resistance-Associated ProteinsVascular ResistanceAnti-Bacterial AgentsDeoxycytidineColonic NeoplasmsProdrugsAdenocarcinomaRadiation OncologyRadiation-Sensitizing AgentsGamma RaysSurvival RateDrug Resistance, ViralDrug Resistance, Multiple, Bacterial